Nexalin Technology (NXL) Equity Ratio (2021 - 2026)
Nexalin Technology's quarterly Equity Ratio came in at 0.78 in Q1 2026, down 2.57% year-on-year from 0.8 in Q1 2025, and down 3.38% quarter-over-quarter from 0.81 in Q4 2025.
Nexalin Technology has reported Equity Ratio for 6 years, with the latest figure at 0.78 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 2.57% year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (down 2.57% YoY), and the FY2025 full-year result was 0.81, down 7.12% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.78, down from 0.81 in the prior quarter.
- The five-year high for Equity Ratio was 0.94 in Q3 2024, with the low at 0.73 in Q3 2023.
- Average Equity Ratio over 5 years is 0.83, with a median of 0.81 recorded in 2025.
- Year-over-year, Equity Ratio jumped 133.03% in 2022 and decreased 7.12% in 2025.
- Tracing NXL's Equity Ratio over 5 years: stood at 0.74 in 2022, then grew by 19.77% to 0.88 in 2023, then retreated by 1.4% to 0.87 in 2024, then slipped by 7.12% to 0.81 in 2025, then slipped by 3.38% to 0.78 in 2026.
- The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.81 (Q4 2025), and 0.93 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.93 |
| Jun 30, 2025 | 0.91 |
| Mar 31, 2025 | 0.80 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 0.86 |
| Mar 31, 2024 | 0.82 |
| Dec 31, 2023 | 0.88 |
| Sep 30, 2023 | 0.73 |
| Jun 30, 2023 | 0.77 |
| Mar 31, 2023 | 0.80 |
| Dec 31, 2022 | 0.74 |
| Sep 30, 2022 | 0.76 |
| Dec 31, 2021 | -2.23 |